Abstract
The COVID-19 pandemic altered health care delivery for various dermatologic conditions; however, there is a paucity of data about hidradenitis suppurativa (HS). We investigated the COVID-19 experience of patients with HS during the pandemic. We performed retrospective chart reviews and telephone surveys of 90 patients seen at the Einstein/Montefiore HS Center between May and August 2020. Participants were mostly female (73.3%) with a mean age of 36.7 ± 13.7 years. The mean HS-Physician Global Assessment (HS-PGA) score, a marker of disease severity, was 2.48 ± 1.32.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
